Literature DB >> 28178427

Pathogenesis of Colitis in Germ-Free Mice Infected With EHEC O157:H7.

K A Eaton1, C Fontaine1, D I Friedman1, N Conti1, C J Alteri1.   

Abstract

Enterohemorrhagic Escherichia coli (EHEC) are strains of E. coli that express Shiga toxins (Stx) and cause hemorrhagic colitis. In some cases, disease can progress to hemolytic uremic syndrome, a potentially fatal form of kidney disease. Both enteric and renal disease are associated with the expression of stx genes, which are often carried on lysogenic phage. Toxin is expressed following induction and conversion of the phage to lytic growth. The authors previously used a germ-free mouse model to demonstrate that toxin gene expression is enhanced during growth in vivo and that renal disease is dependent on both prophage induction and expression of Stx2. In the current study, the authors document and quantify necrotizing colitis, examine the progression of enteric and renal disease, and determine the role of Stx2, phage genes, and the type 3 secretion system (T3SS) in bacterial colonization and colitis and systemic disease. By 1 day after inoculation, EHEC-monocolonized mice developed colitis, which decreased in severity thereafter. Systemic disease developed subsequently. Infection with EHEC mutant strains revealed that renal failure and splenic necrosis were absolutely dependent on the expression of Stx2 but that T3SS function and prophage excision were not necessary for systemic disease. In contrast, colitis was only partly dependent on Stx2. This study demonstrates that in germ-free mice, like in human patients, EHEC causes early colitis followed by renal failure and that systemic disease but not colitis is Stx2 dependent.

Entities:  

Keywords:  Escherichia coli; animal models; bacterial infections; gastrointestinal diseases; germ-free; mice; pathogenicity; virulence factors

Mesh:

Substances:

Year:  2017        PMID: 28178427      PMCID: PMC5474182          DOI: 10.1177/0300985817691582

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  42 in total

1.  Intestinal damage in enterohemorrhagic Escherichia coli infection.

Authors:  Zivile D Békássy; Carla Calderon Toledo; Gustav Leoj; Anncharlotte Kristoffersson; Shana R Leopold; Maria-Thereza Perez; Diana Karpman
Journal:  Pediatr Nephrol       Date:  2010-09-01       Impact factor: 3.714

Review 2.  Enteropathogenic and enterohemorrhagic Escherichia coli virulence gene regulation.

Authors:  Jay L Mellies; Alex M S Barron; Anna M Carmona
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

3.  Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7.

Authors:  E A Wadolkowski; J A Burris; A D O'Brien
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

Review 4.  Animal Models of Enterohemorrhagic Escherichia coli Infection.

Authors:  Jennifer M Ritchie
Journal:  Microbiol Spectr       Date:  2014-08

5.  Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II.

Authors:  E A Wadolkowski; L M Sung; J A Burris; J E Samuel; A D O'Brien
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

6.  The locus of enterocyte effacement (LEE)-encoded regulator controls expression of both LEE- and non-LEE-encoded virulence factors in enteropathogenic and enterohemorrhagic Escherichia coli.

Authors:  S J Elliott; V Sperandio; J A Girón; S Shin; J L Mellies; L Wainwright; S W Hutcheson; T K McDaniel; J B Kaper
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

7.  Commensal bacteria influence Escherichia coli O157:H7 persistence and Shiga toxin production in the mouse intestine.

Authors:  Shantini D Gamage; Angela K Patton; Jane E Strasser; Claudia L Chalk; Alison A Weiss
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

8.  Interaction of enterohemorrhagic Escherichia coli O157:H7 with mouse intestinal mucosa.

Authors:  Francis Girard; Gad Frankel; Alan D Phillips; William Cooley; Ute Weyer; Alexandra H A Dugdale; Martin J Woodward; Roberto M La Ragione
Journal:  FEMS Microbiol Lett       Date:  2008-04-16       Impact factor: 2.742

9.  Nonpathogenic Escherichia coli can contribute to the production of Shiga toxin.

Authors:  Shantini D Gamage; Jane E Strasser; Claudia L Chalk; Alison A Weiss
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  Ability of Escherichia coli O157:H7 isolates to colonize the intestinal tract of conventional adult CD1 mice is transient.

Authors:  J W Conlan; S L Bardy; R KuoLee; A Webb; M B Perry
Journal:  Can J Microbiol       Date:  2001-01       Impact factor: 2.419

View more
  3 in total

1.  Citrobacter rodentium Lysogenized with a Shiga Toxin-Producing Phage: A Murine Model for Shiga Toxin-Producing E. coli Infection.

Authors:  Laurice J Flowers; Shenglan Hu; Anishma Shrestha; Amanda J Martinot; John M Leong; Marcia S Osburne
Journal:  Methods Mol Biol       Date:  2021

2.  Pathogenic and non-pathogenic Escherichia coli colonization and host inflammatory response in a defined microbiota mouse model.

Authors:  Zachary R Stromberg; Angelica Van Goor; Graham A J Redweik; Meghan J Wymore Brand; Michael J Wannemuehler; Melha Mellata
Journal:  Dis Model Mech       Date:  2018-11-16       Impact factor: 5.758

3.  Mcc1229, an Stx2a-Amplifying Microcin, Is Produced In Vivo and Requires CirA for Activity.

Authors:  Erin M Nawrocki; Laura E Hutchins; Kathryn A Eaton; Edward G Dudley
Journal:  Infect Immun       Date:  2021-12-06       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.